United Therapeutics (UTHR) Stock News
$UTHR · NASDAQ · 2 stories in 30 days$531.87
1D −1.78%1W +2.55%1M +10.66%
BORSA has published 2 stories on United Therapeutics (UTHR) in the past 30 days. BORSA’s news read on UTHR is bullish at 70/100, −1 over 24 hours, based on 1 company event over the past 7 days. UTHR last closed at $550.10 on Oct 12, up 2.55% over five sessions and up 10.66% over the past month. United Therapeutics’ next earnings report is scheduled for Wednesday, Nov 4.
The wire on $UTHR
newest first · updated · direct subject stories onlyUnited Therapeutics reports positive data for ralinepag and treprostinil at CHEST 2026
United Therapeutics presented data at CHEST 2026 showing ralinepag reduced clinical worsening risk in PAH and nebulized treprostinil reduced disease progression in IPF. FDA has accepted NDAs for both drugs.
bullish 70 · impact 60